Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015;14(20):3211-2.
doi: 10.1080/15384101.2015.1086200.

Resistance to EGFR-targeted therapy by Ets-1 inactivation

Osamu Tetsu  1   2 , David W Eisele  1   2 , Frank McCormick  1
Affiliations
Editorial

Resistance to EGFR-targeted therapy by Ets-1 inactivation

Osamu Tetsu et al. Cell Cycle. 2015.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Summary of the molecular mechanism of EGFR inhibition and innate drug resistance in EGFR-mutated NSCLC cells. Increases and decreases in activity/expression of signaling molecules or biological outcomes resulting from EGFR inhibition are indicated by red arrows.
See this image and copyright information in PMC

Comment on

References

    1. Rosell R, et al.. Lancet Oncol 2012; 13:239-46; PMID:22285168; http://dx.doi.org/10.1016/S1470-2045(11)70393-X - DOI - PubMed
    1. Wilson TR, et al.. Nature 2012; 487:505-9; PMID:22763448; http://dx.doi.org/10.1038/nature11249 - DOI - PMC - PubMed
    1. Phuchareon J, et al.. Proc Natl Acad Sci U S A 2015; 112:E3855-63; PMID:26150526; http://dx.doi.org/10.1073/pnas.1510733112 - DOI - PMC - PubMed
    1. Tricker EM, et al.. Cancer Discov 2015; 5:960–971;PMID:26036643; http://cancerdiscovery.aacrjournals.org/content/5/9/960.abstract?etoc
    1. Ercan D, et al.. Cancer Discov 2012; 2:934-47; PMID:22961667; http://dx.doi.org/10.1158/2159-8290.CD-12-0103 - DOI - PMC - PubMed

MeSH terms

Substances